Skip to main content
. 2016 Oct 17;6:35205. doi: 10.1038/srep35205

Figure 2. miR-127 exacerbated dysfunction after SCT.

Figure 2

(a) miR-127 exacerbated the locomotor function deficit following SCT. Functional recovery in hindlimb was assessed from week 1 to week 9 after SCT with Basso, Beattie, and Bresnahan (BBB) Scores. Hindlimb dysfunction was exacerbated with treatment of miR-127 agomir when compared with NS-miRNA group. Three independent experiments were performed and the data are presented as the means ± SEM. *P < 0.05, **P < 0.01, compared with NS-miRNA group. n = 5 at least/group. (b) Tail-flick latency (TL) in each group was evaluated at 28 days after SCT. Data were presented as means ± SEM. *P < 0.05, **P < 0.01, compared with NS-miRNA group. n = 5/group. (c,d) Latency and amplitude of SSEPs signals in each group was evaluated at 28 days after SCT. Data were presented as means ± SEM. *P < 0.05 versus sham group, #P < 0.05 versus NS-miRNA group. n = 5/group.